title: Preclinical studies of MRX-115: safety evaluations of a myocardial perfusion agent.
authors.affiliation: ImaRx Pharmaceutical Corp., Tucson, AZ 85719, USA.
authors.forename: T
authors.initials: T
authors.lastname: Fritz
authors.forename: M
authors.initials: M
authors.lastname: McKeon
authors.forename: E
authors.initials: E
authors.lastname: Unger
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury / Q000473:pathology; D003287:Contrast Media / Q000633:toxicity*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004452:Echocardiography; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D005466:Fluorocarbons / Q000633:toxicity*; D007275:Injections, Intravenous; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008297:Male; D009152:Mutagenicity Tests; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D003287:Contrast Media; D005466:Fluorocarbons; C042852:perflutren